Literature DB >> 25276766

Thromboembolism and Thrombosis during Pregnancy and After Delivery between 2009 and 2012 in Al-Zahra Educational Center.

Zahra Fardiazar1, Khadijeh Hajizadeh2, Soudabeh Dinparvar3, Fariba Esmaili4.   

Abstract

Venous thromboembolism (VTE) is considered as one of the leading causes of maternal mortality during pregnancy and postpartum period. In this retrospective study the medical records of 81 women diagnosed with Pulmonary thromboembolism (PTE) and Deep venous thrombosis (DVT) between 2009 and 2012 in Tabriz Al-Zahra hospital was participated. These cases were evaluated regarding frequency, maternal and fetus risk factors associated with VTE. During 3 years 33 patients were diagnosed as PTE; 7 women were diagnosed as DVT and PTE; and 41 women were diagnosed as DVT. Most frequent underlying disease was hypertension (13.5%) and most frequent symptoms of PTE and DVT were dyspnea (100%) and swelling of lower limb (100%) respectively. 93% of PTE and 79% of DVT incidences occurred during and after the third trimester of pregnancy. Additionally, 38% of PTE occurred during or after childbirth (33% following cesarean and 5% following vaginal delivery). Therefore, it seems that vaginal delivery is safer than cesarean surgery. In addition, the importance of third trimester of pregnancy and postpartum period is obvious.

Entities:  

Keywords:  Post partum period; Pregnancy; Risk factors; Thromboembolism

Year:  2014        PMID: 25276766      PMCID: PMC4171820          DOI: 10.5681/jcs.2014.024

Source DB:  PubMed          Journal:  J Caring Sci        ISSN: 2251-9920


  16 in total

1.  Short communication: imaging pulmonary embolism in pregnancy: what is the most appropriate imaging protocol?

Authors:  S Matthews
Journal:  Br J Radiol       Date:  2006-05       Impact factor: 3.039

2.  Evaluation of suspected pulmonary embolism in pregnancy.

Authors:  Charles Gregory Elliott
Journal:  J Thorac Imaging       Date:  2012-01       Impact factor: 3.000

Review 3.  Safety of low-molecular-weight heparin in pregnancy: a systematic review.

Authors:  B J Sanson; A W Lensing; M H Prins; J S Ginsberg; Z S Barkagan; E Lavenne-Pardonge; B Brenner; M Dulitzky; J D Nielsen; Z Boda; S Turi; M R Mac Gillavry; K Hamulyák; I M Theunissen; B J Hunt; H R Büller
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

4.  Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation.

Authors:  J G Ray; W S Chan
Journal:  Obstet Gynecol Surv       Date:  1999-04       Impact factor: 2.347

5.  Heparin therapy during pregnancy. Risks to the fetus and mother.

Authors:  J S Ginsberg; G Kowalchuk; J Hirsh; P Brill-Edwards; R Burrows
Journal:  Arch Intern Med       Date:  1989-10

6.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

Review 7.  Venous thromboembolism during pregnancy.

Authors:  Lee T Dresang; Pat Fontaine; Larry Leeman; Valerie J King
Journal:  Am Fam Physician       Date:  2008-06-15       Impact factor: 3.292

Review 8.  Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy.

Authors:  S Gillis; A Shushan; A Eldor
Journal:  Int J Gynaecol Obstet       Date:  1992-12       Impact factor: 3.561

9.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

10.  Pulmonary thromboembolism in pregnancy: Diagnostic imaging and related consideration.

Authors:  Maryam Moradi
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.